Search - tctmd.com

Displaying 341 - 360 of 426

Sort: Relevancy | Date

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

News Daily News

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

December 05, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

Presentation TCT 2012

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Presenter: Rajesh Dave

October 25, 2012

Presentation TCT 2012

Part 2: Antiplatelet Agents

Presenter: Robert Harrington

October 25, 2012

News Industry News

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

October 25, 2012

News Conference News TCT 2012

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Conference News TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

October 24, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Daily News

Efficacy of Clopidogrel Diminished in Diabetics After MI

September 07, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

Advertisement

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Part 2: Antiplatelet Agents

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Dabigatran Usage up, Both for A-fib and Off-Label Indications

Efficacy of Clopidogrel Diminished in Diabetics After MI

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content